Alpha Capital Management’s Medtronic MDT Stock Holding History

Alpha Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-35,757	Closed	-$2.78M	–	116
2023 Q2	$2.78M	Hold	35,757	–	–	0.69%	54
2023 Q1	$2.78M	Hold	35,757	–	–	0.69%	54
2022 Q4	$2.78M	Buy	35,757 +1,036	+3%	+$84K	0.69%	54
2022 Q3	$2.8M	Buy	34,721 +1,952	+6%	+$175K	0.74%	53
2022 Q2	$2.94M	Buy	32,769 +3,621	+12%	+$367K	0.8%	53
2022 Q1	$3.23M	Buy	29,148 +3,208	+12%	+$339K	0.7%	52
2021 Q4	$2.68M	Buy	25,940 +279	+1%	+$32.3K	0.59%	60
2021 Q3	$3.22M	Buy	25,661 +861	+3%	+$111K	0.76%	44
2021 Q2	$3.08M	Buy	24,800 +1,223	+5%	+$154K	0.72%	46
2021 Q1	$2.79M	Buy	23,577 +562	+2%	+$65.9K	0.71%	43
2020 Q4	$2.7M	Buy	23,015 +26	+0.1%	+$2.86K	0.68%	48
2020 Q3	$2.39M	Sell	22,989 -1,540	-6%	-$155K	0.69%	47
2020 Q2	$2.25M	Buy	+24,529	New	+$2.35M	0.77%	47

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Alpha Capital Management's MDT Position: Q3 2023 in Review

Alpha Capital Management sold out of Medtronic (MDT) in Q3 2023, closing a stake of 35,757 shares — an estimated $2.78M sold.

Alpha Capital Management first reported a position in MDT in Q2 2020 and held it in 13 quarters. The position peaked at $3.23M in Q1 2022. 1,971 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

Alpha Capital Management reported no remaining Medtronic position as of Q3 2023 after selling out during the quarter.
Alpha Capital Management sold 35,757 Medtronic shares in Q3 2023, an estimated $2.78M.
Alpha Capital Management first reported a position in Medtronic in Q2 2020 and held it in 13 quarters.
Alpha Capital Management's Medtronic position peaked at $3.23M in Q1 2022.
1,971 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on Alpha Capital Management's 13F filing for Q3 2023, filed 17 Oct 2023.